119
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Mitotane liposomes for potential treatment of adrenal cortical carcinoma: ex vivo intestinal permeation and in vivo bioavailability

, , , , , , ORCID Icon & show all
Pages 949-961 | Received 14 Jun 2019, Accepted 27 Apr 2020, Published online: 19 May 2020

References

  • Ali MH, Moghaddam B, Kirby DJ, Mohammed AR, Perrie Y. 2013. The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs. Int J Pharm. 453:225–232.
  • Alves GP, Santana MH. 2004. Phospholipid dry powders produced by spray drying processing: structural, thermodynamic and physical properties. Powder Technol. 145:139–148.
  • Amidon G, Lennernãs H, Shah VP, Crison JR. 1995. A theoretical basis for a biopharmaceutical drug classification: the correlation of in vivo drug product dissolution and in vivo bioavailability. Pharm Res. 12:414–420.
  • Asare EA, Wang TS, Winchester DP, Mallin K, Kebebew E, Sturgeon C. 2014. A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease. Surgery. 156:1378–1385. discussion 1385–1376.
  • Attivi D, Ajana I, Astier A, Demore B, Gibaud S. 2010. Development of microemulsion of mitotane for improvement of oral bioavailability. Drug Dev Ind Pharm. 36:421–427.
  • Barlaskar FM, Hammer GD. 2007. The molecular genetics of adrenocortical carcinoma. Rev Endocr Metab Disord. 8:343–348.
  • Barthe L, Bessouet M, Woodley J, Houin G. 1998. The improved everted gut sac: a simple method to study intestinal P-glycoprotein. Int J Pharm. 173:255–258.
  • Barthe L, Woodley J, Houin G. 1999. Gastrointestinal absorption of drugs: methods and studies. Fundam Clin Pharmacol. 13:154–168.
  • Chen PS, Toribara TY, Warner H. 1956. Microdetermination of phosphorus. Anal Chem. 28:1756–1758.
  • Clares B, Calpena AC, Parra A, Abrego G, Alvarado H, Fangueiro JF, Souto EB. 2014. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation. Int J Pharm. 473:591–598.
  • Copland MJ, Rades T, Davies NM. 2000. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes. Int J Pharm. 196:135–139.
  • da Silva CF, Severino P, Martins F, Chaud MV, Santana M. 2009. The intestinal permeation of didanosine from granules containing microspheres using the everted gut sac model. J Microencapsulation. 26:523–528.
  • Daeihamed M, Dadashzadeh S, Haeri A, Akhlaghi MF. 2017. Potential of liposomes for enhancement of oral drug absorption. Curr Drug Deliv. 14:289–303.
  • Daghastanli KR, Ferreira RB, Thedei G Jr, Maggio B, Ciancaglini P. 2004. Lipid composition-dependent incorporation of multiple membrane proteins into liposomes. Colloids Surf B Biointerfaces. 36:127–137.
  • de Paula Rigoletto T, Silva CL, Santana MHA, Rosada RS, de la Torre LG. 2012. Effects of extrusion, lipid concentration and purity on physico-chemical and biological properties of cationic liposomes for gene vaccine applications. J Microencapsulation. 29:759–769.
  • Desai MP, Labhasetwar V, Amidon GL, Levy RJ. 1996. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res. 13:1838–1845.
  • Diez C, Traag W, Zommer P, Marinero P, Atienza J. 2006. Comparison of an acetonitrile extraction/partitioning and “dispersive solid-phase extraction” method with classical multi-residue methods for the extraction of herbicide residues in barley samples. J Chromatogr A. 1131:11–23.
  • Edwards KA, Baeumner AJ. 2006. Analysis of liposomes. Talanta. 68:1432–1441.
  • FDA. 2008. [accessed 2015 Sep 23]. http://www.fda.gov/ohrms/dockets/ac/01/slides/3763s2_10_KUMI.PPT
  • Frohlich E, Roblegg E. 2012. Models for oral uptake of nanoparticles in consumer products. Toxicology. 291:10–17.
  • Grando CRC, Guimarães CA, Mercuri LP, Matos JR, Santana M. 2013. Preparation and characterization of solid lipid nanoparticles loaded with racemic mitotane. J Coll Sci Biotechnol. 2:140–145.
  • Hantel C, Jung S, Mussack T, Reincke M, Beuschlein F. 2014. Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model. Endocr Relat Cancer. 21:383–394.
  • He P, Davis SS, Illum L. 1998. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm. 166:75–88.
  • Hermansson V, Cantillana T, Hovander L, Bergman A, Ljungvall K, Magnusson U, Törneke K, Brandt I. 2008. Pharmacokinetics of the adrenocorticolytic compounds 3-methylsulphonyl-DDE and o,p’-DDD (mitotane) in Minipigs. Cancer Chemother Pharmacol. 61:267–274.
  • Jung S, Nagy Z, Fassnacht M, Zambetti G, Weiss M, Reincke M, Igaz P, Beuschlein F, Hantel C. 2016. Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma. Endocr Relat Cancer. 23:825–837.
  • Kukuchi H, Yamauchi H, Hirota S. 1991. A spray-drying method for mass production of liposomes. Chem Pharm Bull. 39:1522–1527.
  • Lee D, Yanamadala V, Shankar GM, Shin JH. 2016. Metastatic adrenal cortical carcinoma to T12 vertebrae. J Clin Neurosci. 27:166–169.
  • Li SS, Tang XY, Zhang SG, Ni SL, Yang NB, Lu MQ. 2016. Voriconazole combined with low-dose amphotericin B liposome for treatment of cryptococcal meningitis. Infect Dis. 48:563–563.
  • Lin YH, Chen YS, Wu TC, Chen LJ. 2011. Enhancement of dissolution rate of mitotane and warfarin prepared by using microemulsion systems. Colloids Surf B Biointerfaces. 85:366–372.
  • Maiter D, Bex M, Vroonen L, T'Sjoen G, Gil T, Banh C, Chadarevian R. 2016. Efficacy and safety of mitotane in the treatment of adrenocortical carcinoma: a retrospective study in 34 Belgian patients. Ann Endocrinol (Paris). 77:578–585.
  • Makwana K, Tandel H. 2012. Design and characterization of anionic PEGylated liposomal formulation loaded with paclitax for ovarian cancer. J Pharm Bioall Sci. 4:17–18.
  • Manirakiza P, Covaci A, Schepens P. 2000. Single step clean-up and GC-MS quantification of organochlorine pesticide residues in spice powder. Chromatographia. 52:787–790.
  • Misra A, Jinturkar K, Patel D, Lalani J, Chougule M. 2009. Recent advances in liposomal dry powder formulations: preparation and evaluation. Expert Opinion on Drug Delivery. 6:71–89.
  • Moolenaar A, Van Slooten H, Van Seters A, Smeenk D. 1981. Blood levels of o, p′-DDD following administration in various vehicles after a single dose and during long-term treatment. Cancer Chemother Pharmacol. 7:51–54.
  • Nguyen XT, Pabarue HA, Geyer RR, Shroyer LA, Estey LA, Parilo MS, Wilson KS, Prochaska LJ. 2002. Biochemical and biophysical properties of purified phospholipid vesicles containing bovine heart cytochrome c oxidase. Protein Expr Purif. 26:122–130.
  • Ohashi K, Hayashi T, Sakamoto M, Iuchi H, Suzuki H, Ebisawa T, Tojo K, Sasano H, Utsunomiya K. 2016. Aldosterone-producing adrenocortical carcinoma with prominent hepatic metastasis diagnosed by liver biopsy: a case report. BMC Endocr Disord. 16:3.
  • Pashirova TN, Zueva IV, Petrov KA, Lukashenko SS, Nizameev IR, Kulik NV, Voloshina AD, Almasy L, Kadirov MK, Masson P, et al. 2018. Mixed cationic liposomes for brain delivery of drugs by the intranasal route: the acetylcholinesterase reactivator 2-PAM as encapsulated drug model. Colloids Surf B Biointerfaces. 171:358–367.
  • Petersen GH, Alzghari SK, Chee W, Sankari SS, La-Beck NM. 2016. Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin. J Controlled Release. 232:255–264.
  • Pianovski MA, Maluf EM, de Carvalho DS, Ribeiro RC, Rodriguez-Galindo C, Boffetta P, Zancanella P, Figueiredo BC. 2006. Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba. Pediatr Blood Cancer. 47:56–60.
  • Pudipeddi M, Serajuddin AT. 2005. Trends in solubility of polymorphs. J Pharm Sci. 94:929–939.
  • Rodrigues MV, Reyes FG, Magalhães PM, Rath S. 2007. GC-MS determination of organochlorine pesticides in medicinal plants harvested in Brazil. J Braz Chem Soc. 18:135–142.
  • Severino P, Moraes LF, Zanchetta B, Souto EB, Santana MH. 2012. Elastic liposomes containing benzophenone-3 for sun protection factor enhancement. Pharm Dev Technolo. 17:661–665.
  • Severino P, Pinho SC, Souto EB, Santana MH. 2011. Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles. Colloids Surf B Biointerfaces. 86:125–130.
  • Severino P, Souto EB, Pinho SC, Santana MH. 2013. Hydrophilic coating of mitotane-loaded lipid nanoparticles: preliminary studies for mucosal adhesion. Pharm Dev Technol. 18:577–581.
  • Souto EB. 2009. A special issue on lipid-based delivery systems (liposomes, lipid nanoparticles, lipid matrices and medicines). J Biomed Nanotechnol. 5:315–316.
  • Souto EB, Souto SB, Campos JR, Severino P, Pashirova TN, Zakharova LY, Silva AM, Durazzo A, Lucarini M, Izzo AA, et al. 2019. Nanoparticle delivery systems in the treatment of diabetes complications. Molecules. 24:4209.
  • Stigliano A, Cerquetti L, Lardo P, Petrangeli E, Toscano V. 2017. New insights and future perspectives in the therapeutic strategy of adrenocortical carcinoma. Oncol Rep. 37:1301–1311.
  • Teixeira MC, Carbone C, Souto EB. 2017. Beyond liposomes: recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery. Prog Lipid Res. 68:1–11.
  • Westover EJ, Lin X, Riehl TE, Ma L, Stenson WF, Covey DF, Ostlund RE. 2006. Rapid transient absorption and biliary secretion of enantiomeric cholesterol in hamsters. J Lipid Res. 47:2374–2381.
  • Xu YZ, Zhu Y. 2013. Conventional chemotherapy and emerging targeted therapy for advanced adrenocortical carcinoma. Anticancer Agents Med Chem. 13:248–253.
  • Yin F, Guo S, Gan Y, Zhang X. 2014. Preparation of redispersible liposomal dry powder using an ultrasonic spray freeze-drying technique for transdermal delivery of human epithelial growth factor. Int J Nanomedicine. 9:1665–1676.
  • Zancanella P, Pianovski MAD, Oliveira BH, Ferman S, Piovezan GC, Lichtvan LL, Voss SZ, Stinghen ST, Callefe LG, Parise GA, et al. 2006. Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression. J Pediatr Hematol Oncol. 28:513–524.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.